BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29212113)

  • 21. Comparison of the CHA
    Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA
    Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.
    Lip GYH; Lane DA; Buller H; Apostolakis S
    Chest; 2013 Dec; 144(6):1839-1847. PubMed ID: 24009027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points?
    Nielsen PB; Larsen TB; Lip GYH
    Chest; 2016 Feb; 149(2):311-314. PubMed ID: 26356508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
    García-Fernández A; Marín F; Roldán V; Galcerá-Jornet E; Martínez-Martínez JG; Valdés M; Sogorb F; Lip GY
    Int J Cardiol; 2016 Aug; 217():42-8. PubMed ID: 27179207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.
    Esteve-Pastor MA; Rivera-Caravaca JM; Roldán V; Sanmartin Fernández M; Arribas F; Masjuan J; Barrios V; Cosin-Sales J; Freixa-Pamias R; Recalde E; Pérez-Cabeza AI; Manuel Vázquez Rodríguez J; Ràfols Priu C; Anguita Sánchez M; Lip GYH; Marin F
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):38-46. PubMed ID: 36318457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
    Pisters R; Lane DA; Nieuwlaat R; de Vos CB; Crijns HJ; Lip GY
    Chest; 2010 Nov; 138(5):1093-100. PubMed ID: 20299623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Kiviniemi T; Puurunen M; Schlitt A; Rubboli A; Karjalainen P; Vikman S; Niemelä M; Lahtela H; Lip GY; Airaksinen KE
    Am J Cardiol; 2014 Jun; 113(12):1995-2001. PubMed ID: 24793675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth Differentiation Factor-15 Based ABC (Age, Biomarkers, Clinical History)-AF (Atrial Fibrillation)-Bleeding Risk Score for Elderly Patients with Nonvalvular Atrial Fibrillation.
    O UF; Chong TK; Wei Y; Lo CI; Wu W
    J Healthc Eng; 2022; 2022():2863815. PubMed ID: 35299688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project.
    Guo YT; Zhang Y; Shi XM; Shan ZL; Wang CJ; Wang YT; Chen YD; Lip GY
    Sci Rep; 2016 Aug; 6():31755. PubMed ID: 27557876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.
    Hijazi Z; Oldgren J; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Held C; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Granger CB; Wallentin L;
    Lancet; 2016 Jun; 387(10035):2302-2311. PubMed ID: 27056738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.
    Serna MJ; Rivera-Caravaca JM; Gonzalez-Conejero R; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Roldán V; Marín F
    Eur J Clin Invest; 2018 Jun; 48(6):e12929. PubMed ID: 29577257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
    Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive performance of HAS-BLED risk score for long-term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation.
    Hsieh MJ; Lee CH; Chen CC; Chang SH; Wang CY; Hsieh IC
    J Cardiol; 2017 Jan; 69(1):136-143. PubMed ID: 26951606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.
    Hilkens NA; Algra A; Greving JP
    Stroke; 2017 Nov; 48(11):3142-3144. PubMed ID: 28931618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HAS-BLED Score Predicts the Risk of Major Bleeding in Chronic Anticoagulation after Lower Limb Surgical Revascularization.
    Freixo C; Ferreira V; Gonçalves J; Teixeira G; Antunes I; Veiga C; Mendes D; Veterano C; Martins J; Almeida R
    Ann Vasc Surg; 2019 Aug; 59():190-194. PubMed ID: 31028853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK; Kiviniemi T; Schlitt A; Rubboli A; Dietrich B; Karjalainen P; Nyman K; Niemelä M; Lip GY; Airaksinen KE
    Thromb Res; 2014 Apr; 133(4):560-6. PubMed ID: 24461143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?
    Esteve-Pastor MA; García-Fernández A; Macías M; Sogorb F; Valdés M; Roldán V; Muñiz J; Badimon L; Roldán I; Bertomeu-Martínez V; Cequier Á; Lip GY; Anguita M; Marín F;
    Circ J; 2016 Sep; 80(10):2102-8. PubMed ID: 27557850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HAS-BLED Score is Associated With Major Bleeding in Patients After Cardiac Surgery.
    Santise G; Nardella S; Migliano F; Testa A; Maselli D
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1601-1606. PubMed ID: 30732919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.